Lv2
130 积分 2023-04-27 加入
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
3小时前
待确认
Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
5个月前
已完结
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
5个月前
已完结
Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data
6个月前
已完结
Cadonilimab: First Approval
6个月前
已完结
Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary
7个月前
已完结
Good response of cadonilimab (PD-1/CTLA-4 Bi-specific antibody) to patients with advanced lung adenocarcinoma after immunotherapy resistance: A case report
8个月前
已完结
Immunotherapy rechallenge of advanced lung adenocarcinoma with cardonilimab (PD-1/CTLA-4 Bi-specific antibody): a case report
8个月前
已完结
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study
8个月前
已完结
Successful Osimertinib Rechallenge After Relapse Following Adjuvant Osimertinib: A Case Report
8个月前
已完结
皖公网安备34019202002308
